|
130-10807B-50
|
RayBiotech, Inc.
|
Mouse anti-SARS-COV-2-S1RBD (1H9-G1-A1) [+Biotin], Mouse Monoclonal Antibody
|
Virus (81% cross-reactivity with N501Y, 61% cross-reactivity with E484K, and 4% cross-reactivity with E484K, N501Y, K417N)
|
ELISA (recommended work dilution = 1:320,000)<br><br>Neutralization was measured by ability to inhibit entry of pseudovirus harboring the SARS-CoV-2 spike protein into A549 cells. This antibody was also demonstrated to block S1 RBD-ACE2 binding <em>in vitro</em>.
|
|
|
130-10849B-50
|
RayBiotech, Inc.
|
Mouse anti-SARS-CoV-2 S1RBD (5G12-F1-H11) [+Biotin], Mouse Monoclonal Antibody
|
Virus (61% cross-reactivity with N501Y, 99% cross-reactivity with E484K, and 54% cross-reactivity with E484K, N501Y, K417N)
|
ELISA (recommended work dilution = 1:320,000)
|
|
|
130-10860B-50
|
RayBiotech, Inc.
|
Mouse anti-SARS-CoV-2 S1RBD (3H3-D1-B10) [+Biotin], Mouse Monoclonal Antibody
|
Virus (73% cross-reactivity with N501Y, 99% cross-reactivity with E484K, and 78% cross-reactivity with E484K, N501Y, K417N)
|
ELISA (recommended work dilution = 1:160,000)
|
|
|
130-10867B-50
|
RayBiotech, Inc.
|
Mouse anti-SARS-CoV-2 S1RBD (1B9-H12-A12) [+Biotin], Mouse Monoclonal Antibody
|
Virus (76% cross-reactivity with N501Y, 100% cross-reactivity with E484K, and 62% cross-reactivity with E484K, N501Y, K417N)
|
ELISA (recommended work dilution = 1:160,000)
|
|
|
130-10876B-50
|
RayBiotech, Inc.
|
Mouse anti-SARS-CoV-2 S1RBD (1D5-H12-F11) [+Biotin], Mouse Monoclonal Antibody
|
Virus (2% cross-reactivity with N501Y, 72% cross-reactivity with E484K, and 2% cross-reactivity with E484K, N501Y, K417N)
|
ELISA (recommended work dilution = 1:160,000)
|
|
|
130-10877B-50
|
RayBiotech, Inc.
|
Mouse anti-SARS-CoV-2 S1RBD (1E2-B1-A2) [+Biotin], Mouse Monoclonal Antibody
|
Virus (17% cross-reactivity with N501Y, 95% cross-reactivity with E484K, and 92% cross-reactivity with E484K, N501Y, K417N)
|
ELISA (recommended work dilution = 1:160,000)
|
|
